These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36129018)

  • 21. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
    Samanta A; Alam SSM; Ali S; Hoque M
    Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico study of SARS-CoV-2 spike protein RBD and human ACE-2 affinity dynamics across variants and Omicron subvariants.
    Abeywardhana S; Premathilaka M; Bandaranayake U; Perera D; Peiris LDC
    J Med Virol; 2023 Jan; 95(1):e28406. PubMed ID: 36519577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
    Ali N; Khan R; AlAsmari AF; Kumar V
    Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.
    Bagheri M; Niavarani A
    J Biomol Struct Dyn; 2022 Mar; 40(4):1597-1606. PubMed ID: 33030105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is BF.7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF.7 spike RBD variant.
    Singh JK; Anand S; Srivastava SK
    Int J Biol Macromol; 2023 May; 238():124154. PubMed ID: 36965551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2.
    Deepthi V; Mohanakumar KP; Rajamma U
    J Biomol Struct Dyn; 2023 Apr; 41(7):2911-2925. PubMed ID: 35189779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes.
    Dutta S; Panthi B; Chandra A
    J Phys Chem B; 2022 Jul; 126(29):5375-5389. PubMed ID: 35833966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies.
    Singh JK; Dubey S; Srivastava G; Siddiqi MI; Srivastava SK
    Comput Biol Med; 2023 Jan; 152():106392. PubMed ID: 36502697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracycline as an inhibitor to the SARS-CoV-2.
    Zhao TY; Patankar NA
    J Cell Biochem; 2021 Jul; 122(7):752-759. PubMed ID: 33619758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.
    Song Y; Qayyum S; Greer RA; Slominski RM; Raman C; Slominski AT; Song Y
    J Biomol Struct Dyn; 2022; 40(22):11594-11610. PubMed ID: 34415218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of E484Q and L452R Mutations on Structure and Binding Behavior of SARS-CoV-2 B.1.617.1 Using Deep Learning AlphaFold2, Molecular Docking and Dynamics Simulation.
    Jiao Y; Xing Y; Sun Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South Brazil.
    Sant'Anna FH; Finger Andreis T; Salvato RS; Muterle Varela AP; Comerlato J; Gregianini TS; Barcellos RB; de Souza Godinho FM; Resende PC; da Luz Wallau G; Y Castro TR; Casarin BC; de Almeida Vieira A; Schwarzbold AV; de Arruda Trindade P; Tumioto Giannini GL; Freese L; Bristot G; Brasil CS; de Oliveira Rocha B; Martins PB; de Oliveira FH; van Oosterhout C; Wendland E
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2.
    Golcuk M; Yildiz A; Gur M
    J Mol Graph Model; 2022 Dec; 117():108286. PubMed ID: 35964366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-atom simulations of the trimeric spike protein of SARS-CoV-2 in aqueous medium: Nature of interactions, conformational stability and free energy diagrams for conformational transition of the protein.
    Panthi B; Dutta S; Chandra A
    J Comput Chem; 2023 Jun; 44(17):1560-1577. PubMed ID: 37000187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of mutations modulating enhanced transmissibility of SARS-CoV-2 B.1.617+ (Delta) variant using In Silico tools.
    Shahhosseini N
    Gene Rep; 2022 Jun; 27():101636. PubMed ID: 35721780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.
    Wu J; Zhang HX; Zhang J
    Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.